Thyroid disorder — all decisions

The appeal of the claims for service connection for thyroid cancer and hypothyroidism as secondary to thyroid cancer is dismissed as the benefits have been granted in full.

The Board remands the claims for service connection for non-Hodgkin's lymphoma and hypothyroidism due to insufficient evidence of specific exposure details.

The Board denied service connection for various disabilities, including cervical spine, back, shoulder, elbow, wrist, vertigo, and hypothyroidism, as there was no evidence of an in-service event, injury, illness, or disease related to these disabilities. The claim for a sleep apnea disability was also denied due to the lack of a current diagnosis.

The Board granted restoration of a 100 percent rating for hypothyroidism and SMC, from August 1, 2024, but remanded the issue of entitlement to a rating in excess of 30 percent for chronic kidney disease.

The Board denied service connection for hyperthyroidism and remanded the claim for a prostate condition due to insufficient evidence.

The Board denied higher ratings for hypothyroidism and Parkinson's Disease residuals, but granted earlier effective dates for some service-connected conditions.

The Board granted service connection for bronchitis and increased the rating for asthma with COPD to 60 percent, while denying service connection for hyperthyroidism, sarcoidosis, a lung condition other than asthma, TDIU from July 29, 2016, to March 15, 2017, and special monthly compensation (SMC) based upon aid and attendance/housebound status.

The Board denied the Veteran's claims for increased ratings and service connection, as well as remanded several other claims for further development.

The Board remands the claims for service connection for hypothyroidism, hypertension, coronary artery disease, diabetes mellitus type II, and peripheral neuropathy to obtain additional research and medical opinions regarding potential exposures.

The veteran withdrew the appeal before a decision was made, and therefore the appeal is dismissed.

The Board remands the claim for a medical opinion to determine if there is a link between the Veteran's thyroid cancer and herbicide exposure in Vietnam.

The veteran withdrew his appeal for service connection for multiple conditions, including peripheral neuropathy, COPD, gout, PTSD, OSA, and a thyroid condition.

The Board remands the matters of an initial compensable disability rating for hypothyroidism and an effective date earlier than January 1, 2021 for service connection for hypothyroidism due to an inadequate VA examination.

The Board denied the Veteran's claims for service connection for a sinus condition and thyroid condition, as there is no evidence to support that these conditions are related to his active-duty service.

The Board denied service connection for a right middle finger condition, hypothyroidism, and an acquired psychiatric disorder. The claim for GERD was remanded.

The Board granted an effective date of August 30, 2011, for the grant of service connection for hypothyroidism.

The Board dismissed the appeals for service connection for sleep apnea, cholesterol disability, and thyroid disability due to an untimely Notice of Disagreement (NOD). The appeal regarding an increased rating for residuals status post gunshot wound, left ankle, was remanded.

The Board granted service connection for obstructive sleep apnea and remanded several other claims, including those for essential tremors (parkinsonism), psychiatric disability, hypothyroidism, hearing loss, ischemic heart disease, pulmonary/ respiratory disability, blood clots, and aortic aneurysm.

The Board granted earlier effective dates for thyroid and prostate cancer service connection, denied increased ratings for psychiatric disorder and tinnitus, granted an increased rating for prostate cancer residuals, and granted service connection for erectile dysfunction.

The Board denied service connection for thyroid disability as there is no evidence of a connection between the Veteran's service and his current hypothyroidism.